Sacituzumab Tirumotecan: Clinical Trials

1 trial for Sacituzumab Tirumotecan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Sacituzumab Tirumotecan: new trials by email Literature Review of Sacituzumab Tirumotecan trials Research Report on Sacituzumab Tirumotecan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum
Sacituzumab Tirumotecan - Phase 2, Sacituzumab Tirumotecan
Phase 2Not yet recruitingM.D. Anderson Cancer Center202026-09-252026-10-02

Narrower conditions

Neoplasm Metastasis (1)

Broader conditions

Neoplasms (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Van Morris, MD (1)